Translating the human genome project into prevention of myocardial infarction and stroke - Getting close?

JAMA

Volumn 293, Issue 18, 2005, Pages 2277-2279

  O'Donnell, Christopher J ^a,b  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b FRAMINGHAM HEART STUDY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARACHIDONATE 5 LIPOXYGENASE ACTIVATING PROTEIN; BIOLOGICAL MARKER; C REACTIVE PROTEIN; 5-LIPOXYGENASE-ACTIVATING PROTEIN; CARRIER PROTEIN; LIPOXYGENASE INHIBITOR; MEMBRANE PROTEIN;

CLINICAL TRIAL; EDITORIAL; GENE MAPPING; GENETIC ASSOCIATION; GENETIC LINKAGE; GENETIC RISK; GENETIC VARIABILITY; GENOME ANALYSIS; GENOTYPE; HEART INFARCTION; HUMAN; NUCLEOTIDE SEQUENCE; PREVENTION AND CONTROL; PRIORITY JOURNAL; STATISTICAL ANALYSIS; STROKE; CARDIOVASCULAR DISEASE; CEREBROVASCULAR ACCIDENT; DRUG ANTAGONISM; GENETICS; NOTE; RISK FACTOR;

CARDIOVASCULAR DISEASES; CARRIER PROTEINS; CEREBROVASCULAR ACCIDENT; HUMANS; LIPOXYGENASE INHIBITORS; MEMBRANE PROTEINS; MYOCARDIAL INFARCTION; RISK FACTORS;

EID: 18244396932     PISSN: 00987484     EISSN: None     Source Type: Journal    
DOI: 10.1001/jama.293.18.2277     Document Type: Editorial

References (20)

1. Finishing the euchromatic sequence of the human genome. Nature. 2004;431: 931-945.
2. Brown MS, Goldstein JL. Heart attacks: gone with the century? Science. 1996; 272:629.
3. Marenberg ME, Risch N, Berkman LF, Floderus B, de Faire U. Genetic susceptibility to death from coronary heart disease in a study of twins. N Engl J Med. 1994;330:1041-1046.
4. Lloyd-Jones DM, Nam BH, D'Agostino RB Sr, et al. Parental cardiovascular disease as a risk factor for cardiovascular disease in middle-aged adults: a prospective study of parents and offspring. JAMA. 2004;291:2204-2211.
5. Hakonarson H, Thorvaldsson S, Helgadottir A, et al. Effects of a 5-lipoxygenase-activating protein inhibitor on biomarkers associated with risk of myocardial infarction: a randomized trial. JAMA. 2005;293:2245-2256.
6. Helgadottir A, Manolescu A, Thorleifsson G, et al. The gene encoding 5-lipoxygenase activating protein confers risk of myocardial infarction and stroke. Nat Genet. 2004;36:233-239.
7. Genome vikings. Nat Genet. 1998;20:99-101.
8. Lander E, Kruglyak L. Genetic dissection of complex traits: guidelines for interpreting and reporting linkage results. Nat Genet. 1995;11:241-247.
9. Broeckel U, Hengstenberg C, Mayer B, et al. A comprehensive linkage analysis for myocardial infarction and its related risk factors. Nat Genet. 2002;30:210-214.
10. Chiodini BD, Lewis CM. Meta-analysis of 4 coronary heart disease genomewide linkage studies confirms a susceptibility locus on chromosome 3q. Arterioscler Thromb Vasc Biol. 2003;23:1863-1868.
11. Hauser ER, Crossman DC, Granger CB, et al. A genomewide scan for early-onset coronary artery disease in 438 families: the GENECARD study. Am J Hum Genet. 2004;75:436-447.
12. Wang Q, Rao S, Shen GQ, et al. Premature myocardial infarction novel susceptibility locus on chromosome 1P34-36 identified by genomewide linkage analysis. Am J Hum Genet. 2004;74:262-271.
13. Fox CS, Cupples LA, Chazaro I, et al. Genomewide linkage analysis for internal carotid artery intimal medial thickness: evidence for linkage to chromosome 12. Am J Hum Genet. 2004;74:253-261.
14. Helgadottir A, Gretarsdottir S, St Clair D, et al. Association between the gene encoding 5-lipoxygenase-activating protein and stroke replicated in a Scottish population. Am J Hum Genet. 2005;76:505-509.
15. Lohmueller KE, Pearce CL, Pike M, Lander ES, Hirschhorn JN. Meta-analysis of genetic association studies supports a contribution of common variants to susceptibility to common disease. Nat Genet. 2003;33:177-182.
16. Newton-Cheh C, O'Donnell CJ. Sex differences and genetic associations with myocardial infarction. JAMA. 2004;291:3008-3010.
17. Danesh J, Wheeler JG, Hirschfield GM, et al. C-reactive protein and other circulating markers of inflammation in the prediction of coronary heart disease. N Engl J Med. 2004;350:1387-1397.
18. Ridker PM, Rifai N, Rose L, Buring JE, Cook NR. Comparison of C-reactive protein and low-density lipoprotein cholesterol levels in the prediction of first cardiovascular events. N Engl J Med. 2002;347:1557-1565.
19. Ridker PM, Cannon CP, Morrow D, et al. C-reactive protein levels and outcomes after statin therapy. N Engl J Med. 2005;352:20-28.
20. Solomon SD, McMurray JJ, Pfeffer MA, et al. Cardiovascular risk associated with celecoxib in a clinical trial for colorectal adenoma prevention. N Engl J Med. 2005;352:1071-1080.